top
Search terms
Results 1 - 5 of 5 - ordered by :
Escardio

While the investigator-initiated study showed that DAPT (a combination of aspirin and the P2Y12-receptor blocker clopidogrel) does not decrease the rate of major adverse cardiovascular and ...

Date : 31/08/2015
Escardio

(1) Professor Keith Fox, principal investigator, University of Edinburgh, UK, said: “These findings challenge the use of combined oral anticoagulant and antiplatelet therapy in patients with ...

Date : 28/08/2018
Escardio

AUGUSTUS was a prospective, multicenter, two-by-two factorial, randomized clinical trial, supported by the pharmaceutic industry, including 4614 patients with atrial fibrillation who had a recent ...

Date : 06/05/2019
Escardio

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018
Escardio

The findings were clear, but unexpected. “Since plaque erosion or rupture, thromboembolism, spontaneous coronary dissection and microvascular disorders are commonly encountered in MINOCA ...

Date : 01/09/2019